Year |
Citation |
Score |
2021 |
Shimizu K, Gi M, Suzuki S, North BJ, Watahiki A, Fukumoto S, Asara JM, Tokunaga F, Wei W, Inuzuka H. Interplay between protein acetylation and ubiquitination controls MCL1 protein stability. Cell Reports. 37: 109988. PMID 34758305 DOI: 10.1016/j.celrep.2021.109988 |
0.356 |
|
2019 |
Cheng J, Guo J, North BJ, Wang B, Cui CP, Li H, Tao K, Zhang L, Wei W. Functional analysis of deubiquitylating enzymes in tumorigenesis and development. Biochimica Et Biophysica Acta. Reviews On Cancer. 188312. PMID 31449841 DOI: 10.1016/J.Bbcan.2019.188312 |
0.406 |
|
2018 |
Cheng J, Guo J, North BJ, Tao K, Zhou P, Wei W. The emerging role for Cullin 4 family of E3 ligases in tumorigenesis. Biochimica Et Biophysica Acta. Reviews On Cancer. PMID 30602127 DOI: 10.1016/J.Bbcan.2018.11.007 |
0.33 |
|
2018 |
Ma Y, Cui D, Xiong X, Inuzuka H, Wei W, Sun Y, North BJ, Zhao Y. SCFβ-TrCP ubiquitinates CHK1 in an AMPK-dependent manner in response to glucose deprivation. Molecular Oncology. PMID 30428154 DOI: 10.1002/1878-0261.12403 |
0.326 |
|
2018 |
Ci Y, Li X, Chen M, Zhong J, North BJ, Inuzuka H, He X, Li Y, Guo J, Dai X. SCFE3 ubiquitin ligase targets the tumor suppressor ZNRF3 for ubiquitination and degradation. Protein & Cell. PMID 29497989 DOI: 10.1007/S13238-018-0510-2 |
0.335 |
|
2017 |
Cheng J, Guo J, Wang Z, North BJ, Tao K, Dai X, Wei W. Functional analysis of Cullin 3 E3 ligases in tumorigenesis. Biochimica Et Biophysica Acta. PMID 29128526 DOI: 10.1016/J.Bbcan.2017.11.001 |
0.403 |
|
2017 |
Tan Y, Ci Y, Dai X, Wu F, Guo J, Liu D, North BJ, Huo J, Zhang J. Cullin 3SPOP ubiquitin E3 ligase promotes the poly-ubiquitination and degradation of HDAC6. Oncotarget. PMID 28599312 DOI: 10.18632/Oncotarget.18141 |
0.446 |
|
2017 |
Wang B, Jie Z, Joo D, Ordureau A, Liu P, Gan W, Guo J, Zhang J, North BJ, Dai X, Cheng X, Bian X, Zhang L, Harper JW, Sun SC, et al. TRAF2 and OTUD7B govern a ubiquitin-dependent switch that regulates mTORC2 signalling. Nature. PMID 28489822 DOI: 10.1038/Nature22344 |
0.382 |
|
2017 |
North BJ, Almeciga-Pinto I, Tamang D, Yang M, Jones SS, Quayle SN. Enhancement of pomalidomide anti-tumor response with ACY-241, a selective HDAC6 inhibitor. Plos One. 12: e0173507. PMID 28264055 DOI: 10.1371/Journal.Pone.0173507 |
0.34 |
|
2017 |
Nihira NT, Ogura K, Shimizu K, North BJ, Zhang J, Gao D, Inuzuka H, Wei W. Acetylation-dependent regulation of MDM2 E3 ligase activity dictates its oncogenic function. Science Signaling. 10. PMID 28196907 DOI: 10.1126/Scisignal.Aai8026 |
0.381 |
|
2017 |
Shimizu K, Fukushima H, Ogura K, Lien EC, Nihira NT, Zhang J, North BJ, Guo A, Nagashima K, Nakagawa T, Hoshikawa S, Watahiki A, Okabe K, Yamada A, Toker A, et al. The SCFβ-TRCP E3 ubiquitin ligase complex targets Lipin1 for ubiquitination and degradation to promote hepatic lipogenesis. Science Signaling. 10. PMID 28049764 DOI: 10.1126/Scisignal.Aah4117 |
0.318 |
|
2016 |
Li X, Dai X, Wan L, Inuzuka H, Sun L, North BJ. Smurf1 regulation of DAB2IP controls cell proliferation and migration. Oncotarget. PMID 27036023 DOI: 10.18632/Oncotarget.8424 |
0.437 |
|
2015 |
Rumpf T, Schiedel M, Karaman B, Roessler C, North BJ, Lehotzky A, Oláh J, Ladwein KI, Schmidtkunz K, Gajer M, Pannek M, Steegborn C, Sinclair DA, Gerhardt S, Ovádi J, et al. Selective Sirt2 inhibition by ligand-induced rearrangement of the active site. Nature Communications. 6: 6263. PMID 25672491 DOI: 10.1038/Ncomms7263 |
0.34 |
|
2014 |
Wu X, Fukushima H, North BJ, Nagaoka Y, Nagashima K, Deng F, Okabe K, Inuzuka H, Wei W. SCFβ-TRCP regulates osteoclastogenesis via promoting CYLD ubiquitination. Oncotarget. 5: 4211-21. PMID 24961988 DOI: 10.18632/Oncotarget.1971 |
0.379 |
|
2014 |
Dai X, North BJ, Inuzuka H. Negative regulation of DAB2IP by Akt and SCFFbw7 pathways. Oncotarget. 5: 3307-15. PMID 24912918 DOI: 10.18632/Oncotarget.1939 |
0.42 |
|
2012 |
Bonezzi K, Belotti D, North BJ, Ghilardi C, Borsotti P, Resovi A, Ubezio P, Riva A, Giavazzi R, Verdin E, Taraboletti G. Inhibition of SIRT2 potentiates the anti-motility activity of taxanes: implications for antineoplastic combination therapies. Neoplasia (New York, N.Y.). 14: 846-54. PMID 23019416 DOI: 10.1593/Neo.12728 |
0.552 |
|
2012 |
Price NL, Gomes AP, Ling AJ, Duarte FV, Martin-Montalvo A, North BJ, Agarwal B, Ye L, Ramadori G, Teodoro JS, Hubbard BP, Varela AT, Davis JG, Varamini B, Hafner A, et al. SIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial function. Cell Metabolism. 15: 675-90. PMID 22560220 DOI: 10.1016/J.Cmet.2012.04.003 |
0.333 |
|
2011 |
Beirowski B, Gustin J, Armour SM, Yamamoto H, Viader A, North BJ, Michán S, Baloh RH, Golden JP, Schmidt RE, Sinclair DA, Auwerx J, Milbrandt J. Sir-two-homolog 2 (Sirt2) modulates peripheral myelination through polarity protein Par-3/atypical protein kinase C (aPKC) signaling. Proceedings of the National Academy of Sciences of the United States of America. 108: E952-61. PMID 21949390 DOI: 10.1073/Pnas.1104969108 |
0.31 |
|
2008 |
Bonezzi K, North B, Manzotti C, Riva A, Verdin E, Giavazzi R, Taraboletti G. 452 POSTER Tubulin acetylation and the antimotility effects of tubulin-targeting agents European Journal of Cancer Supplements. 6: 142. DOI: 10.1016/S1359-6349(08)72386-3 |
0.408 |
|
2007 |
North BJ, Verdin E. Interphase nucleo-cytoplasmic shuttling and localization of SIRT2 during mitosis. Plos One. 2: e784. PMID 17726514 DOI: 10.1371/Journal.Pone.0000784 |
0.577 |
|
2007 |
Ahuja N, Schwer B, Carobbio S, Waltregny D, North BJ, Castronovo V, Maechler P, Verdin E. Regulation of insulin secretion by SIRT4, a mitochondrial ADP-ribosyltransferase. The Journal of Biological Chemistry. 282: 33583-92. PMID 17715127 DOI: 10.1074/Jbc.M705488200 |
0.647 |
|
2007 |
North BJ, Verdin E. Mitotic regulation of SIRT2 by cyclin-dependent kinase 1-dependent phosphorylation. The Journal of Biological Chemistry. 282: 19546-55. PMID 17488717 DOI: 10.1074/Jbc.M702990200 |
0.562 |
|
2007 |
North BJ, Sinclair DA. Sirtuins: a conserved key unlocking AceCS activity. Trends in Biochemical Sciences. 32: 1-4. PMID 17141505 DOI: 10.1016/J.Tibs.2006.11.002 |
0.402 |
|
2005 |
North BJ, Schwer B, Ahuja N, Marshall B, Verdin E. Preparation of enzymatically active recombinant class III protein deacetylases. Methods (San Diego, Calif.). 36: 338-45. PMID 16091304 DOI: 10.1016/J.Ymeth.2005.03.004 |
0.674 |
|
2005 |
Waltregny D, Glénisson W, Tran SL, North BJ, Verdin E, Colige A, Castronovo V. Histone deacetylase HDAC8 associates with smooth muscle alpha-actin and is essential for smooth muscle cell contractility. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 19: 966-8. PMID 15772115 DOI: 10.1096/Fj.04-2303Fje |
0.544 |
|
2005 |
Pagans S, Pedal A, North BJ, Kaehlcke K, Marshall BL, Dorr A, Hetzer-Egger C, Henklein P, Frye R, McBurney MW, Hruby H, Jung M, Verdin E, Ott M. SIRT1 regulates HIV transcription via Tat deacetylation. Plos Biology. 3: e41. PMID 15719057 DOI: 10.1371/Journal.Pbio.0030041 |
0.532 |
|
2004 |
Waltregny D, North B, Van Mellaert F, De Leval J, Verdin E, Castronovo V. Screening of histone deacetylases (HDAC) expression in human prostate cancer reveals distinct class I HDAC profiles between epithelial and stromal cells European Journal of Histochemistry. 48: 273-290. PMID 15590418 DOI: 10.4081/897 |
0.556 |
|
2004 |
Waltregny D, De Leval L, Glénisson W, Ly Tran S, North BJ, Bellahcène A, Weidle U, Verdin E, Castronovo V. Expression of histone deacetylase 8, a class I histone deacetylase, is restricted to cells showing smooth muscle differentiation in normal human tissues. The American Journal of Pathology. 165: 553-64. PMID 15277229 DOI: 10.1016/S0002-9440(10)63320-2 |
0.581 |
|
2004 |
North BJ, Verdin E. Sirtuins: Sir2-related NAD-dependent protein deacetylases. Genome Biology. 5: 224. PMID 15128440 DOI: 10.1186/Gb-2004-5-5-224 |
0.577 |
|
2004 |
Verdin E, Dequiedt F, Fischle W, Frye R, Marshall B, North B. Measurement of Mammalian Histone Deacetylase Activity Methods in Enzymology. 377: 180-196. PMID 14979025 DOI: 10.1016/S0076-6879(03)77010-4 |
0.552 |
|
2003 |
North BJ, Marshall BL, Borra MT, Denu JM, Verdin E. The human Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin deacetylase. Molecular Cell. 11: 437-44. PMID 12620231 DOI: 10.1016/S1097-2765(03)00038-8 |
0.604 |
|
2002 |
Verzi MP, Anderson JP, Dodou E, Kelly KK, Greene SB, North BJ, Cripps RM, Black BL. N-twist, an evolutionarily conserved bHLH protein expressed in the developing CNS, functions as a transcriptional inhibitor. Developmental Biology. 249: 174-90. PMID 12217327 DOI: 10.1006/Dbio.2002.0753 |
0.338 |
|
2002 |
Schwer B, North BJ, Frye RA, Ott M, Verdin E. The human silent information regulator (Sir)2 homologue hSIRT3 is a mitochondrial nicotinamide adenine dinucleotide-dependent deacetylase. The Journal of Cell Biology. 158: 647-57. PMID 12186850 DOI: 10.1083/Jcb.200205057 |
0.664 |
|
Show low-probability matches. |